21-Mar-17 Researchers at Sandia National Laboratories in the US have developed a smartphone-controlled, battery-operated, diagnostic device for the detection of Zika, dengue, and chikungunya. The new device eliminates the need for laboratory testing and reduces wait times from several days, to around 30 minutes and would cost in the region of USD100. [image: ET Healthworld]

17-Mar-17 TPG, the US alternative-investment firm, sees opportunities in healthcare in Asia to meet untapped demand in some of the fastest-growing economies. The region is short of quality healthcare infrastructure, said Jim Coulter, co-CEO. TPG’s Asian investment arm manages USD6 bn in assets, including a stake in the United Family Healthcare chain of high-end Chinese hospitals. [image: Bloomberg]

16-Mar-17 The USA has long been a top destination for travellers from Gulf Coast Countries seeking healthcare treatments abroad. Since Donald Trump's travel ban was announced, travel bookings from the countries covered have decreased by 80%. With Emiratis alone, travelling abroad for treatment spending USD250,000 per-visit, American specialist facilities are rightly concerned over the implications the ban might have. [image: Arab Health]

05-Mar-17 With India becoming a popular destination for medical tourism, Mengaluru is joining the trend. Efficiency, low costs and state-of-the-art hospitals are making the city a sought after destination. KMC Hospital has seen a sharp increase in international patients. Over the past 10 months, KMC catered to >100 international patients from the Middle East, Bangladesh, Nigeria, Kenya, UK and US. [image: The Times Of India]

 Articles

Chinese citizens are leaving their homes in search of the best care available, or care that they desperately need. Some 483,000 people travelled outbound from China for healthcare in 2015. These medical travellers spent USD6.3 billion on treatment and a further USD3.4 billion on travel and accommodation.